PF-07976016
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 10
Of
10
Go to page
1
May 05, 2025
Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=21 | Active, not recruiting | Sponsor: Pfizer | N=32 ➔ 21 | Recruiting ➔ Active, not recruiting
Enrollment change • Enrollment closed • Genetic Disorders • Obesity
April 07, 2025
Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Pfizer
New P1 trial • Genetic Disorders • Obesity
March 11, 2025
A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults
(clinicaltrials.gov)
- P1 | N=12 | Completed | Sponsor: Pfizer | Recruiting ➔ Completed
Trial completion
December 26, 2024
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
(clinicaltrials.gov)
- P2 | N=252 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
December 05, 2024
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
(clinicaltrials.gov)
- P2 | N=252 | Not yet recruiting | Sponsor: Pfizer
New P2 trial • Genetic Disorders • Obesity
November 12, 2024
A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open
November 01, 2024
A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Pfizer
New P1 trial
September 23, 2024
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
(clinicaltrials.gov)
- P1 | N=117 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed
Trial completion
June 26, 2024
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
(clinicaltrials.gov)
- P1 | N=110 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting
Enrollment closed
April 23, 2024
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
(clinicaltrials.gov)
- P1 | N=146 | Recruiting | Sponsor: Pfizer | Trial completion date: Mar 2024 ➔ Sep 2024 | Trial primary completion date: Mar 2024 ➔ Sep 2024
Trial completion date • Trial primary completion date
1 to 10
Of
10
Go to page
1